Stay updated on Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Sign up to get notified when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision history shows the addition of Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure as well as Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T22:40:57.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision history now shows Revision: v3.3.2 as the latest entry, and Revision: v3.2.0 has been removed.
    Difference
    0.1%
    Check dated 2025-11-25T11:49:01.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Removed the banner warning about a lapse in government funding and potential downtime. The prior notice indicated that site information might not be up to date and that inquiries could be delayed.
    Difference
    0.6%
    Check dated 2025-11-18T07:15:21.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The screenshots show minor UI adjustments and an additional version entry in the record history; no substantive changes to study details are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:22:50.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page now adds current date references and a study status update, while removing an older date reference.
    Difference
    1.0%
    Check dated 2025-10-20T14:19:12.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.
    Difference
    11%
    Check dated 2025-10-06T05:50:52.000Z thumbnail image

Stay in the know with updates to Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.